SERAFINI, Marta
 Distribuzione geografica
Continente #
NA - Nord America 302
AS - Asia 124
EU - Europa 62
Totale 488
Nazione #
US - Stati Uniti d'America 302
SG - Singapore 97
IT - Italia 23
ID - Indonesia 15
DE - Germania 14
FI - Finlandia 12
CN - Cina 8
GB - Regno Unito 4
IE - Irlanda 3
CH - Svizzera 2
FR - Francia 2
IN - India 2
AT - Austria 1
HK - Hong Kong 1
NL - Olanda 1
TW - Taiwan 1
Totale 488
Città #
Santa Clara 203
Singapore 80
Columbus 27
Jakarta 15
Helsinki 12
Falkenstein 10
Turin 7
Chandler 5
West Jordan 4
Dublin 3
Ipswich 3
Lonato 3
Nuremberg 3
Central Point 2
Lausanne 2
Rovereto 2
Ashburn 1
Guangzhou 1
Hyderabad 1
London 1
Nanjing 1
Taichung 1
Totale 387
Nome #
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy 45
Store-Operated Calcium Entry as a Therapeutic Target in Acute Pancreatitis: Discovery and Development of Drug-Like SOCE Inhibitors 24
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 23
Applications of deuterium in medicinal chemistry 23
The 115 year old multicomponent Bargellini reaction: Perspectives and new applications 22
The Essential Medicinal Chemistry of Essential Medicines 21
An aryne-based three-component access to α-aroylamino amides 20
A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability 19
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 19
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 19
STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39 19
Erratum: An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline (ACS Medicinal Chemistry Letters (2022) 13: 8 (1278−1285) DOI: 10.1021/acsmedchemlett.2c00166) 18
Mutate and Conjugate: A Method to Enable Rapid In-Cell Target Validation 17
What's in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications 17
1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry 17
Synthesis, docking and biological evaluation of a novel class of imidazothiazoles as IDO1 inhibitors 17
An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline 16
Soft drugs for dermatological applications: recent trends 16
A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies 16
A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs 16
Arynes and isocyanides: Two close-knit partners in multicomponent reactions 16
Tritylamine as an ammonia surrogate in the ugi reaction provides access to unprecedented 5-sulfamido oxazoles using burgess-type reagents 16
The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors 15
Click 1,2,3-triazoles in drug discovery and development: From the flask to the clinic? 15
Drug Discovery for Soft Drugs on TRPV1 and TRPM8 Channels Using the Passerini Reaction 15
A primer of deuterium in drug design 14
The multicomponent Passerini reaction as a means of accessing diversity in structure, activity and properties: Soft and hard vanilloid/cannabinoid modulators 14
The use of 2-hydroxymethyl benzoic acid as an effective water surrogate in the Passerini reaction: A straightforward access to α-hydroxyamides 14
Totale 523
Categoria #
all - tutte 2.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.931


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202319 0 2 2 1 3 4 0 2 2 1 1 1
2023/202491 2 2 0 1 0 0 17 1 26 10 10 22
2024/2025413 4 40 22 36 227 80 4 0 0 0 0 0
Totale 523